Adjuvant formulation structure and composition are critical for the development of an effective vaccine against tuberculosis

One third of the world is infected with Mycobacterium tuberculosis (Mtb) with eight million new cases of active tuberculosis (TB) each year. Development of a new vaccine to augment or replace the only approved TB vaccine, BCG, is needed to control this disease. Mtb infection is primarily controlled...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Orr, Mark T., Fox, Christopher B., Baldwin, Susan L., Sivananthan, Sandra J., Lucas, Elyse, Lin, Susan, Phan, Tony, Moon, James J., Vedvick, Thomas S., Reed, Steven G., Coler, Rhea N.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2013
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3871206/
https://ncbi.nlm.nih.gov/pubmed/23933525
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jconrel.2013.07.030
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky